Chargement…
| Groupe | Position | Pour | Contre | Abst. | Répartition |
|---|---|---|---|---|---|
| EPP | Contre | 33 | 120 | 20 | |
| S&D | Pour | 138 | 0 | 3 | |
| Renew | Pour | 97 | 1 | 0 | |
| Greens/EFA | Pour | 73 | 0 | 0 | |
| ID | Pour | 24 | 22 | 24 | |
| ECR | Pour | 40 | 1 | 22 | |
| The Left | Pour | 35 | 3 | 0 | |
| Non-attached | Pour | 18 | 2 | 17 |
| Pays | Position | Pour | Contre | Abst. | Répartition |
|---|---|---|---|---|---|
| Germany | Pour | 53 | 41 | 0 | |
| France | Pour | 71 | 0 | 8 | |
| Italy | Pour | 39 | 12 | 24 | |
| Spain | Pour | 41 | 12 | 5 | |
| Poland | Pour | 37 | 12 | 2 |
| Romania | Pour | 18 | 10 | 2 |
| Netherlands | Pour | 17 | 8 | 4 |
| Belgium | Pour | 15 | 3 | 3 |
| Czechia | Pour | 12 | 5 | 4 |
| Greece | Pour | 15 | 3 | 3 |
| Hungary | Abstention | 8 | 1 | 12 |
| Portugal | Pour | 18 | 2 | 0 |
| Sweden | Pour | 12 | 5 | 3 |
| Austria | Contre | 9 | 10 | 0 |
| Bulgaria | Pour | 10 | 3 | 2 |
| Denmark | Pour | 9 | 2 | 3 |
| Finland | Pour | 10 | 3 | 1 |
| Slovakia | Pour | 8 | 3 | 3 |
| Ireland | Pour | 13 | 0 | 0 |
| Croatia | Pour | 6 | 0 | 6 |
| Lithuania | Pour | 6 | 4 | 1 |
| Latvia | Pour | 6 | 2 | 0 |
| Slovenia | Pour | 4 | 4 | 0 |
| Estonia | Pour | 5 | 2 | 0 |
| Cyprus | Pour | 6 | 0 | 0 |
| Luxembourg | Pour | 6 | 0 | 0 |
| Malta | Pour | 4 | 2 | 0 |
| 674 |
| 8 |
| 12 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Adopté | 500 | 192 | 2 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Adopté | 397 | 256 | 41 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Adopté | 632 | 50 | 12 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Adopté | 467 | 193 | 34 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Adopté | 676 | 12 | 6 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Adopté | 500 | 191 | 3 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 119 | 546 | 29 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 252 | 411 | 31 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 146 | 539 | 7 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 286 | 375 | 33 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 111 | 574 | 9 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 138 | 549 | 7 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 246 | 415 | 33 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 236 | 419 | 39 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 207 | 429 | 58 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Adopté | 356 | 281 | 57 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 289 | 389 | 16 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 101 | 545 | 46 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 233 | 423 | 38 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Adopté | 403 | 269 | 22 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 286 | 397 | 11 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 210 | 430 | 54 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 248 | 417 | 29 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 314 | 368 | 12 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 127 | 555 | 10 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 116 | 537 | 41 |
| 20/10/2021 | EU transparency in the development, purchase and distribution of COVID-19 vaccines | EU transparency in the development, purchase and distribution of COVID-19 vaccines RSP | Rejeté | 130 | 553 | 9 |